Detection of antibodies to β-amyloid in carriers of the E280A mutation in the presenilin-1 gene;Deteccion de anticuerpos contra el β-amiloide en individuos portadores de la mutacion E280A en el gen de la presenilina-1

Revista de Neurologia

Volumn 29, Issue 12, 1999, Pages 1104-1107

  Toro, F ^a   Lopera, F ^a   Ossa, J ^a   Madrigal, L ^a   Mira, A ^a   Diaz A ^a   Parra, S ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Alzheimer's disease; Antibodies; Cardiolipin; Immune system; Presenilin 1; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CARDIOLIPIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PRESENILIN 1; CARDIOLIPIN ANTIBODY; MEMBRANE PROTEIN;

ADULT; ALZHEIMER DISEASE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HUMAN; IMMUNE SYSTEM; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PATHOGENESIS; CELL MEMBRANE; FEMALE; GENE EXPRESSION; GENETICS; HETEROZYGOTE; HOSPITALIZATION; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; POINT MUTATION;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIBODIES, ANTICARDIOLIPIN; CELL MEMBRANE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HETEROZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POINT MUTATION; SEVERITY OF ILLNESS INDEX;

EID: 0033576369     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2912.99432     Document Type: Article

References (30)

1. Lopera F, Ardila A, Martínez A, Madrigal L, Arango JC, Lemere CA, et al. Clinical features of early onset Alzheimer's disease in a large kindred with an E280A presenilin-1 mutation. Jama 1997; 277: 793-99.
2. Lemere CA, Lopera F, Kosik KS, et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat Med 1996; 2: 1146-50.
3. Ishizuka K, Kimura T, Igata YR, Katsuragi S, Takamatsu J, Miyakawa T. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatr Clin Neurosci 1997; 51: 135-8.
4. Wood JA, Wood PI, Ryan R, Graff-Radford NK, Pilapil C, Robitaille Y, et al. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha-2 macroglobulin and C-reactive protein. Brain Res 1993; 629: 245-52.
5. Lue LF, Brachova L, Civin WH, Rogers J. Inflammation, Aβ deposition and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 1996; 55: 1083-8.
6. Velasquez P, Cribbs DH, Poulos TJ, Tenner AJ. Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis. Nat Med 1997; 3: 77-9.
7. Medal L, Cassatella MA, Szendrei GL, Otvos L, Baron P, Villalba M, et al. Activation of microglial cells by beta amyloid protein and interferon-gamma. Nature 1995; 374: 647-50.
8. Brugge K, Katzman R, Hill LR, Hansen LA, Saitoh T. Serological α1-antichymotrypsin in Down's Syndrome and Alzheimer's disease. Ann Neurol 1992; 32: 193-7.
9. Angelis P, Scharf S, Mander A, Vajda F, Christophidis N. Serum interleukin 6 and interleukin 6 soluble receptor in Alzheimer's disease. Neurosci Lett 1998; 244: 106-8.
10. Licastro F, Morini MC, Davis LJ, Malpassi P, Cucinotta D, Parente R, et al. Increased chemiluminescence response of neutrophils from the peripheral blood of patients with senile dementia of the Alzheimer's type. J Neuroimmunol 1994; 51: 21-6.
11. Solerte SB, Fioravanti M, Severgnini S, Pezza N, Locatelli M, Cerruti N, Terenzi F, et al. Excitatory pattern of gamma-interferon on natural killer cell activity in senile dementia of Alzheimer type. Dement Geriatr Cogn Disord 1997; 8: 308-13.
12. Singh VK. Immune activation model in Alzheimer's disease. Mol Chem Neuropathol 1996; 28: 105-11.
13. Singh VK, Yang YY, Singh FA. Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients. Neurosci Lett 1992; 147: 25-8.
14. McCocci P, Ekman R, Pametti L, Senin V. Antihistone and anti dsD-NA autoantibodies in Alzheimer's disease and vascular dementia. Biol Psychiatry 1993; 34: 380-5.
15. McRae A, Dahlstrom A, Polinsky K, Ling EA. Cerebrospinal fluid microglial antibodies. Potential diagnostic markers for immune mechanisms in Alzheimer's disease. Behav Brain Res 1993; 57: 225-34.
16. Gaskin F, Finley J, Fang O, Xu S, Fu SM. Human antibodies reactive with beta amyloid protein in Alzheimer's disease. J Exp Med 1993; 177: 1181-6.
17. Fang Q, Kannapell CC, Fu SM, Xu S, Gaskin F. VH and VL gene usage by anti beta amyloid autoantibodies in Alzheimer's disease, detection of highly mutated V regions in both heavy and light chains. Clin Immunol Immunopathol 1995; 75: 159-67.
18. Juby A, Davis P, George T, McElhaney J. Anticardiolipin antibodies in two elderly subpopulations. Lupus 1995; 4: 482-5.
19. Levine SR, Welch KMA. The spectrum of neurologic disease associated with anti phospholipid antibodies. Arch Neurol 1987; 44: 876-83.
20. Tomer Y, Buskila D, Shoenfeld Y. Pathogenic significance and diagnostic value of lupus autoantibodies. Int Arch Allergy Immunol 1993; 100: 239-306.
21. Chaleomchan W, Hemachudha T, Sakulramrung R, Deesomchok U. Anti cardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases. J Neurol Sci 1990; 96: 143-51.
22. Frampton G, Winer TB, Cameron JS, Hughes RA. Severe Guillain Barré Syndrome. An association with IgA anti cardiolipin antibody in a series of 92 patients. J Neuroimmunol 1988; 19: 133-9.
23. Kluger A, Ferris SH. Scales for the assessment of Alzheimer's disease. Psychiatr Clin North Am 1991; 14: 309-15.
24. Gilburd B, Stein M, Omer Y, Tanne D, Abramski O, Chapman Y, et al. Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barré Syndrome: Cross reactive or pathogenic? Autoimmunity 1993; 16: 23-7.
25. Schellenberg GD. Genetic dissection of Alzheimer's disease, a heterogeneous disorder. Proc Natl Acad Sci U S A 1995; 92: 8552-9.
26. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat Med 1997; 3: 67-72.
27. Trieb K, Ransmayr G, Sgonc R, Lassman H, Grubeck-Loebestein B. APP peptides stimulate lymphocyte proliferation in normal but not in patients with Alzheimer's disease. Neurobiol Aging 1996; 17: 541-7.
28. Rogers J, Cooper NR, Webster S, Shultz J, McGeer PL, Styren SD, et al. Complement activation by β-amyloid in Alzheimer's disease. Proc Natl Acad Sci U S A 1992; 89: 10016-20.
29. Xu S, Gaskin F. Increased incidence of antibeta amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease. Mech Ageing Dev 1997; 94: 213-22.
30. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-81.